Navigation Links
Scaling the wall of deafness
Date:4/14/2009

Despite modern medicine, one in 1,000 American babies are born deaf. The numbers increase markedly with age, with more than 50% of seniors in the United States experiencing some form of hearing loss.

But the era of the hearing aid, and shouting at aging in-laws, may soon be over. A new, landmark study by a world-renowned geneticist and hearing loss expert at Tel Aviv University has uncovered one of the root causes of deafness.

Prof. Karen Avraham of the Department of Human Molecular Genetics, Sackler School of Medicine at Tel Aviv University, has discovered that microRNAs, tiny molecules that regulate cell functions, help us hear. Found in "hair" cells of the ear, this discovery opens an entirely new window for possible treatments, and a cure for all types of deafness, age-related or genetic.

"Over the last decade, science has found that microRNAs are involved in heart disease, and in cancer, and for the first time ever, our lab shows that these tiny regulators in all our cells can cause deafness," says Prof. Avraham, whose groundbreaking work has previously discovered 4 deafness genes and novel mutations in 15 deafness genes, among 46 known ones.

Understanding the Hard of Hearing

Prof. Avraham's results published this month in the prestigious journal the Proceedings of the National Academy of Science, shows scientists an important factor that could cause deafness. It may lead to potential ways to ameliorate deafness, even in people where the hearing loss has no genetic basis, like after a major injury to the ear. Her recent study investigated mice and zebrafish, but the model holds true for all vertebrates ― including humans, she says. In separate studies in the UK and Spain, mutations in a single microRNA were just reported to cause deafness in humans and mice, showing the importance of microRNAs in the inner ear.

"We've found that 'hair' cell microRNAs are regulators involved
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Emergence of recombinant forms of HIV: dynamics and scaling

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scaling the wall of deafness
Scaling the wall of deafness
(Date:11/24/2009)...action of a remarkable class of ring-shaped protei...e Lawrence Berkeley National Laboratory (Berkeley ...phy beamline at the Advanced Light Source (ALS). T...ression and replication, and are vital to the surv...s agents, such as the human papillomavirus, which ...
(Date:11/24/2009)... fish food is a matter of debate. A high-profile s...t 50 percent of their carbon from trees and leaves...strial and aquatic ecosystems. , But new researc...not likely to be true. Algae provide a much richer...o research published this week in the Proceedings...
(Date:11/23/2009)... The community-associated strain of the deadly sup...to most common antibioticsposes a far greater heal...way into hospitals, according to a study in the De..., The new threat is easily picked up in fitness c...ncreased the overall burden of MRSA within hospita...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2RetireSafe calls the Seniors Health Care Bill of Rights the Real Cure for Older Americans 55197 1RetireSafe calls the Seniors Health Care Bill of Rights the Real Cure for Older Americans 55197 2GSK Advisory 3A Warehouse Theft 55192 1GSK Advisory 3A Warehouse Theft 55192 2Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27 2009 55188 1Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27 2009 55188 2
... Federal Register today a proposed rule to list bl... and gourmets alike, as endangered under the Endan...NOAA Fisheries Service considered the report of a ... is at risk of extinction. , The scientific rev... of black abalone, especially in the areas around ...
...s, a staple of laboratory research, may be key in...: why we sleep. Researchers at the University of P...s advanced online edition of Nature that the round...animal kingdom in displaying this physiology. This...ution and purpose of sleep and sleep-like states i...
... found a new way that DNA can carry out its work t...old used to cast a metal tool can also serve as a ...owing distinct functional roles. , Professor Mano...der Stark report in the January 1 issue of the jou...nces, both strands of a DNA segment can perform us...
Other Biology News:Snoozing worms help Penn researchers explain the evolution of sleep 2MIT reports new twist in microRNA biology 2
(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswire-...veloper and provider of vaccines, announced today ... establish Sinovac (Dalian) Vaccine,Technology Co....elop, produce,and commercialize human-use vaccines...ence in developing and commercializing world-class...
(Date:11/24/2009)... Ambassador to also Visit D... 24, 2009 -- , , ,Who: David Appia, French Ambassa... CEO of the Invest in France Agency, , , , ,What:...to discuss recent pro-business initiatives adopted...l and academic landscape for innovation and develo...
(Date:11/24/2009)..., , ST. LOUIS, Nov. 24 /PRNewswire-FirstC... will be presenting at the NASDAQ OMX conference o...7:45 AM US/CST. Interested parties may listen via ...t http://inve s tor.sig m a a ldrich.com/ ...his file. ,, About Sigma-Aldrich: Sigma-A...
(Date:11/24/2009)..., , SHANGHAI, Nov. 24 /PRNewswire-A...te Food & Drug Administration (SFDA) has appro... for its oral insulin project,(Nodlin), an innovat...D,approval allows Biolaxy to initiate its first ph...order characteristic of high blood glucose and poo...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... With the price of soybean seed...ot;the sweet spot" - the ideal combination of...education director of the North Central Soybean Re...maximize soybean yield and profit potential in 200...EB) February 25, 2009 -- Optimal soybean planting ...
...RISBANE, Australia and SEATTLE, Feb. 24 Implicit,...the clinical-stage,monoclonal antibody IC14 from E...osed consideration combining cash and stock to Lil...14 sales. , "Implicit Bioscience brings substa...tients with immune-mediated disease," commented Pr...
...ALE, N.J., Feb. 24 Synvista Therapeutics, Inc. (...as entered into agreements with the current holder... per share, under which $2,875,000 in accrued divi...d Stock as of December 31, 2008 has been converted...ears from the date of issuance. Interest at the r...
Other Biology Technology:NCSRP Research Director: "Earlier Planting can Increase Soybean Yields" 2NCSRP Research Director: "Earlier Planting can Increase Soybean Yields" 3Implicit Licenses Clinical Stage Antibody Program From Lilly 2Implicit Licenses Clinical Stage Antibody Program From Lilly 3Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 2Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 3Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 4
Lambda Control Kit from ABgene
Mango-Taq DNA Polymerase from Bioline
...aq DNA polymerase. It is a 5'-exo-minus N-terminal...ressed from a gene construct in E. coli, translati...lease domain of the DNA polymerase-encoding gene. ...eat-stable DNA polymerase activity in comparison w...
Oligonucleotides from Thermo Scientific
Biology Products: